Literature DB >> 2575298

Mast cells in ulcerative colitis. Quantitative and ultrastructural studies.

M Balázs1, G Illyés, G Vadász.   

Abstract

The changes in the number and ultrastructure of mast cells were studied in 37 colonoscopical biopsies from patients with ulcerative colitis. Changes in the active stage of the disease and during remission were compared. Cell counts were performed on semithin sections stained with Giemsa after osmium tetroxide fixation. This method overcome the uncertain staining found after formalin fixation. Accumulation of mast cells accompanied by intense degranulation was found to be significant in the active stage of the disease. Two forms of degranulation were observed: discharge of the individual granules and protrusion and detachment of the cytoplasmic processes containing granules. The latter was a sign of rapid degranulation, as described earlier in animal experiments. Mast cells were closely associated with capillary blood vessels, Schwann cells, neural fibres, myofibroblasts and collagenous fibres, and were also present between epithelial cells. It is assumed that close topographic contact may also imply a functional correlation.

Entities:  

Mesh:

Year:  1989        PMID: 2575298     DOI: 10.1007/bf02899101

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  11 in total

1.  Immune regulation of human colonic electrolyte transport in vitro.

Authors:  W A Stack; S J Keely; D P O'Donoghue; A W Baird
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

2.  Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.

Authors:  S E Crowe; G K Luthra; M H Perdue
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

3.  Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

Authors:  T King; W Biddle; P Bhatia; J Moore; P B Miner
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

Review 4.  Mast cell proteases as protective and inflammatory mediators.

Authors:  George H Caughey
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Role of histamine in a rat model of colitis.

Authors:  C M Gelbmann; K E Barrett
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

Review 6.  Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.

Authors:  David S Kotlyar; Mili Shum; Jennifer Hsieh; Wojciech Blonski; David A Greenwald
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 7.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

8.  Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.

Authors:  M Raithel; S Winterkamp; M Weidenhiller; S Müller; E G Hahn
Journal:  Int J Colorectal Dis       Date:  2006-03-31       Impact factor: 2.796

9.  Urinary and faecal N-methylhistamine concentrations do not serve as markers for mast cell activation or clinical disease activity in dogs with chronic enteropathies.

Authors:  Kristin P Anfinsen; Nora Berghoff; Simon L Priestnall; Jan S Suchodolski; Jörg M Steiner; Karin Allenspach
Journal:  Acta Vet Scand       Date:  2014-12-21       Impact factor: 1.695

Review 10.  The role of mast cells in common gastrointestinal diseases.

Authors:  Ali A Siddiqui; Philip B Miner
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.